Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Publications indexed to the term Brain Neoplasms

FacultyTitle
1The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen. (Malta TM, Sabedot TS, Morosini NS, Datta I, Garofano L, Vallentgoed W, Varn FS, Aldape K, D'Angelo F, Bakas S, Barnholtz-Sloan JS, Gan HK, Hasanain M, Hau AC, Johnson KC, Cazacu S, deCarvalho AC, Khasraw M, Kocakavuk E, Kouwenhoven MCM, Migliozzi S, Niclou SP, Niers JM, Ormond DR, Paek SH, Reifenberger G, Sillevis Smitt PA, Smits M, Stead LF, van den Bent MJ, Van Meir EG, Walenkamp A, Weiss T, Weller M, Westerman BA, Ylstra B, Wesseling P, Lasorella A, French PJ, Poisson LM, Consortium The GLASS, Verhaak RGW, Iavarone A, Noushmehr H) Cancer Res 2024 Mar 04;84(5):741-756       1 Citation
1Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium. (Das A, Fernandez NR, Levine A, Bianchi V, Stengs LK, Chung J, Negm L, Dimayacyac JR, Chang Y, Nobre L, Ercan AB, Sanchez-Ramirez S, Sudhaman S, Edwards M, Larouche V, Samuel D, Van Damme A, Gass D, Ziegler DS, Bielack SS, Koschmann C, Zelcer S, Yalon-Oren M, Campino GA, Sarosiek T, Nichols KE, Loret De Mola R, Bielamowicz K, Sabel M, Frojd CA, Wood MD, Glover JM, Lee YY, Vanan M, Adamski JK, Perreault S, Chamdine O, Hjort MA, Zapotocky M, Carceller F, Wright E, Fedorakova I, Lossos A, Tanaka R, Osborn M, Blumenthal DT, Aronson M, Bartels U, Huang A, Ramaswamy V, Malkin D, Shlien A, Villani A, Dirks PB, Pugh TJ, Getz G, Maruvka YE, Tsang DS, Ertl-Wagner B, Hawkins C, Bouffet E, Morgenstern DA, Tabori U) Cancer Discov 2024 Feb 08;14(2):258-273    
1Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures. (Hu LS, D'Angelo F, Weiskittel TM, Caruso FP, Fortin Ensign SP, Blomquist MR, Flick MJ, Wang L, Sereduk CP, Meng-Lin K, De Leon G, Nespodzany A, Urcuyo JC, Gonzales AC, Curtin L, Lewis EM, Singleton KW, Dondlinger T, Anil A, Semmineh NB, Noviello T, Patel RA, Wang P, Wang J, Eschbacher JM, Hawkins-Daarud A, Jackson PR, Grunfeld IS, Elrod C, Mazza GL, McGee SC, Paulson L, Clark-Swanson K, Lassiter-Morris Y, Smith KA, Nakaji P, Bendok BR, Zimmerman RS, Krishna C, Patra DP, Patel NP, Lyons M, Neal M, Donev K, Mrugala MM, Porter AB, Beeman SC, Jensen TR, Schmainda KM, Zhou Y, Baxter LC, Plaisier CL, Li J, Li H, Lasorella A, Quarles CC, Swanson KR, Ceccarelli M, Iavarone A, Tran NL) Nat Commun 2023 Sep 28;14(1):6066       3 Citations
1An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma. (Barkhoudarian G, Badruddoja M, Blondin N, Chowdhary S, Cobbs C, Duic JP, Flores JP, Fonkem E, McClay E, Nabors LB, Salacz M, Taylor L, Vaillant B, Gill J, Kesari S) CNS Oncol 2023 Sep 01;12(3):CNS102       1 Citation
2Role of Advanced MR Imaging in Diagnosis of Neurological Malignancies: Current Status and Future Perspective. (Eraky AM, Beck RT, Treffy RW, Aaronson DM, Hedayat H) J Integr Neurosci 2023 May 15;22(3):73       3 Citations
1Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth. (Alexanian AR, Stoellinger HM, de Araujo Farias V, Quiñones-Hinojosa A) Invest New Drugs 2023 Jun;41(3):371-375    
1Pinless Electromagnetic Neuronavigation During Awake Craniotomies: Technical Pearls, Pitfalls, and Nuances. (Harwick E, Singhal I, Conway B, Mueller W, Treffy R, Krucoff MO) World Neurosurg 2023 Jul;175:e159-e166       1 Citation
1Advanced MR Techniques for Preoperative Glioma Characterization: Part 2. (Hangel G, Schmitz-Abecassis B, Sollmann N, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A, Ozturk-Isik E, Piskin S, Schmainda KM, Svensson SF, Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T, Hirschler L, Smits M, Petr J, Emblem KE) J Magn Reson Imaging 2023 Jun;57(6):1676-1695       12 Citations
1Glioma progression is shaped by genetic evolution and microenvironment interactions. (Varn FS, Johnson KC, Martinek J, Huse JT, Nasrallah MP, Wesseling P, Cooper LAD, Malta TM, Wade TE, Sabedot TS, Brat D, Gould PV, Wöehrer A, Aldape K, Ismail A, Sivajothi SK, Barthel FP, Kim H, Kocakavuk E, Ahmed N, White K, Datta I, Moon HE, Pollock S, Goldfarb C, Lee GH, Garofano L, Anderson KJ, Nehar-Belaid D, Barnholtz-Sloan JS, Bakas S, Byrne AT, D'Angelo F, Gan HK, Khasraw M, Migliozzi S, Ormond DR, Paek SH, Van Meir EG, Walenkamp AME, Watts C, Weiss T, Weller M, Palucka K, Stead LF, Poisson LM, Noushmehr H, Iavarone A, Verhaak RGW, GLASS Consortium) Cell 2022 Jun 09;185(12):2184-2199.e16       141 Citations
5Radio-Pathomic Maps of Cell Density Identify Brain Tumor Invasion beyond Traditional MRI-Defined Margins. (Bobholz SA, Lowman AK, Brehler M, Kyereme F, Duenweg SR, Sherman J, McGarry SD, Cochran EJ, Connelly J, Mueller WM, Agarwal M, Banerjee A, LaViolette PS) AJNR Am J Neuroradiol 2022 May;43(5):682-688       10 Citations
1Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor. (Jiang B, Murray C, Cole BL, Glover JNM, Chan GK, Deschenes J, Mani RS, Subedi S, Nerva JD, Wang AC, Lockwood CM, Mefford HC, Leary SES, Ojemann JG, Weinfeld M, Ene CI) Sci Rep 2022 Mar 30;12(1):5386       4 Citations
1A volume-independent conformity index for stereotactic radiosurgery. (Oh S, Awan MJ, Monroe JI, Liang Y, Wegner RE, Karlovits S, Machtay M, Lo SS, Sloan A, Sohn JW) Med Phys 2022 May;49(5):2931-2937       2 Citations
1Psychiatric symptoms in children with low-grade glioma and craniopharyngioma: A systematic review. (Sherman SJ, Tanaka R, Qaddoumi I) J Psychiatr Res 2022 Apr;148:240-249       7 Citations
1Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy. (Xie XP, Laks DR, Sun D, Ganbold M, Wang Z, Pedraza AM, Bale T, Tabar V, Brennan C, Zhou X, Parada LF) Dev Cell 2022 Jan 10;57(1):32-46.e8       56 Citations
1A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era. (Pfister SM, Reyes-Múgica M, Chan JKC, Hasle H, Lazar AJ, Rossi S, Ferrari A, Jarzembowski JA, Pritchard-Jones K, Hill DA, Jacques TS, Wesseling P, López Terrada DH, von Deimling A, Kratz CP, Cree IA, Alaggio R) Cancer Discov 2022 Feb;12(2):331-355       77 Citations
1Task-based and Resting State Functional MRI in Children. (Maheshwari M, Deshmukh T, Leuthardt EC, Shimony JS) Magn Reson Imaging Clin N Am 2021 Nov;29(4):527-541       1 Citation
1Hormone-Dependent Tumors and Sexuality in the Neuro-Oncology of Women (N.O.W.): Women's Brain Tumors, Gaps in Sexuality Considerations, and a Need for Evidence-Based Guidelines. (Gatson NTN, Boccia ML, Taylor KR, Mack JKO, Fonkem E) Curr Oncol Rep 2021 Aug 27;23(11):127       2 Citations
2Papillary glioneuronal tumors: Distinctive cytological characteristics and cyto-histologic correlation. (Puzyrenko A, Cochran E, Giorgadze T, Nomani L) Ann Diagn Pathol 2021 Aug;53:151757       3 Citations
1BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort. (Vassilakopoulou M, Won M, Curran WJ, Souhami L, Prados MD, Langer CJ, Rimm DL, Hanna JA, Neumeister VM, Melian E, Diaz AZ, Atkins JN, Komarnicky LT, Schultz CJ, Howard SP, Zhang P, Dicker AP, Knisely JPS) Oncology 2021;99(9):580-588       4 Citations
2Clinical Reasoning: A 42-Year-Old Woman With Mysterious Monocytic Meningitis. (Nothem ME, Lee RM, Katz JM, Bergl PA, Obeidat AZ) Neurology 2021 Aug 31;97(9):449-454       1 Citation
1Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance. (Durno C, Ercan AB, Bianchi V, Edwards M, Aronson M, Galati M, Atenafu EG, Abebe-Campino G, Al-Battashi A, Alharbi M, Azad VF, Baris HN, Basel D, Bedgood R, Bendel A, Ben-Shachar S, Blumenthal DT, Blundell M, Bornhorst M, Bronsema A, Cairney E, Rhode S, Caspi S, Chamdin A, Chiaravalli S, Constantini S, Crooks B, Das A, Dvir R, Farah R, Foulkes WD, Frenkel Z, Gallinger B, Gardner S, Gass D, Ghalibafian M, Gilpin C, Goldberg Y, Goudie C, Hamid SA, Hampel H, Hansford JR, Harlos C, Hijiya N, Hsu S, Kamihara J, Kebudi R, Knipstein J, Koschmann C, Kratz C, Larouche V, Lassaletta A, Lindhorst S, Ling SC, Link MP, Loret De Mola R, Luiten R, Lurye M, Maciaszek JL, MagimairajanIssai V, Maher OM, Massimino M, McGee RB, Mushtaq N, Mason G, Newmark M, Nicholas G, Nichols KE, Nicolaides T, Opocher E, Osborn M, Oshrine B, Pearlman R, Pettee D, Rapp J, Rashid M, Reddy A, Reichman L, Remke M, Robbins G, Roy S, Sabel M, Samuel D, Scheers I, Schneider KW, Sen S, Stearns D, Sumerauer D, Swallow C, Taylor L, Thomas G, Toledano H, Tomboc P, Van Damme A, Winer I, Yalon M, Yen LY, Zapotocky M, Zelcer S, Ziegler DS, Zimmermann S, Hawkins C, Malkin D, Bouffet E, Villani A, Tabori U) J Clin Oncol 2021 Sep 01;39(25):2779-2790       32 Citations
1Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and 18F-FMISO PET. (Huang S, Michalek JE, Reardon DA, Wen PY, Floyd JR, Fox PT, Clarke GD, Jerabek PA, Schmainda KM, Muzi M, Hyun H, Lee EQ, Brenner AJ) Sci Rep 2021 Apr 07;11(1):7632       15 Citations
1Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. (Fonkem E, Peng S, Berens M, Mukherjee S) J Neuropathol Exp Neurol 2021 Feb 22;80(3):290-291       1 Citation
1A Preliminary Report on Quality of Life and Sexual Function in Brain Tumor Patients. (Boccia ML, Anyanda EI, Fonkem E) J Sex Med 2021 Apr;18(4):737-742       6 Citations
1Cytokeratin 7, GATA3, and SOX-10 is a Comprehensive Panel in Diagnosing Triple Negative Breast Cancer Brain Metastases. (Statz E, Jorns JM) Int J Surg Pathol 2021 Aug;29(5):470-474       7 Citations
1High prevalence of clonal hematopoiesis-type genomic abnormalities in cell-free DNA in invasive gliomas after treatment. (Okamura R, Piccioni DE, Boichard A, Lee S, Jimenez RE, Sicklick JK, Kato S, Kurzrock R) Int J Cancer 2021 Jun 01;148(11):2839-2847       19 Citations
1Intracranial Capillary Hemangiomas: A Peripartum Presentation and Review of the Literature. (Massman LJ, Conteh F, Cochran EJ, Zwagerman NT) World Neurosurg 2021 Jan;145:220-228       6 Citations
1Dual inhibition of BRAF and mTOR in BRAFV600E -mutant pediatric, adolescent, and young adult brain tumors. (Sen S, Tanaka R, Khatua S, Zaky W, Janku F, Penas-Prado M, Weathers SP, Behrang A, Roszik J, Subbiah V) Cold Spring Harb Mol Case Stud 2020 Aug;6(4)       5 Citations
1Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial. (Schmainda KM, Prah MA, Marques H, Kim E, Barboriak DP, Boxerman JL) Neuro Oncol 2021 Feb 25;23(2):314-323       15 Citations
1Cell Lineage-Based Stratification for Glioblastoma. (Wang Z, Sun D, Chen YJ, Xie X, Shi Y, Tabar V, Brennan CW, Bale TA, Jayewickreme CD, Laks DR, Alcantara Llaguno S, Parada LF) Cancer Cell 2020 Sep 14;38(3):366-379.e8       57 Citations
3Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes. (Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ) Int J Radiat Oncol Biol Phys 2020 Nov 15;108(4):979-986       15 Citations
1Evaluating the Use of rCBV as a Tumor Grade and Treatment Response Classifier Across NCI Quantitative Imaging Network Sites: Part II of the DSC-MRI Digital Reference Object (DRO) Challenge. (Bell LC, Semmineh N, An H, Eldeniz C, Wahl R, Schmainda KM, Prah MA, Erickson BJ, Korfiatis P, Wu C, Sorace AG, Yankeelov TE, Rutledge N, Chenevert TL, Malyarenko D, Liu Y, Brenner A, Hu LS, Zhou Y, Boxerman JL, Yen YF, Kalpathy-Cramer J, Beers AL, Muzi M, Madhuranthakam AJ, Pinho M, Johnson B, Quarles CC) Tomography 2020 Jun;6(2):203-208       10 Citations
4Radiomic Features of Multiparametric MRI Present Stable Associations With Analogous Histological Features in Patients With Brain Cancer. (Bobholz SA, Lowman AK, Barrington A, Brehler M, McGarry S, Cochran EJ, Connelly J, Mueller WM, Agarwal M, O'Neill D, Nencka AS, Banerjee A, LaViolette PS) Tomography 2020 Jun;6(2):160-169       22 Citations
1Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas. (Boxerman JL, Quarles CC, Hu LS, Erickson BJ, Gerstner ER, Smits M, Kaufmann TJ, Barboriak DP, Huang RH, Wick W, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Chung C, van den Bent MJ, Chang S, Al Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Rosen BR, Ellingson BM, Schmainda KM, Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee) Neuro Oncol 2020 Sep 29;22(9):1262-1275       101 Citations
1SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. (Mukherjee S, Stroberg E, Wang F, Morales L, Shan Y, Rao A, Huang JH, Wu E, Fonkem E) J Neuropathol Exp Neurol 2020 May 01;79(5):562-565       5 Citations
1A view of the epidemiologic landscape: how population-based studies can lend novel insights regarding the pathophysiology of glioblastoma. (Tadipatri R, Lyon K, Azadi A, Fonkem E) Chin Clin Oncol 2021 Aug;10(4):35       1 Citation
1Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies. (Hoxworth JM, Eschbacher JM, Gonzales AC, Singleton KW, Leon GD, Smith KA, Stokes AM, Zhou Y, Mazza GL, Porter AB, Mrugala MM, Zimmerman RS, Bendok BR, Patra DP, Krishna C, Boxerman JL, Baxter LC, Swanson KR, Quarles CC, Schmainda KM, Hu LS) AJNR Am J Neuroradiol 2020 Mar;41(3):408-415       17 Citations
1Novel Use of Stimulating Fence-Post Technique for Functional Mapping of Subcortical White Matter During Tumor Resection: A Technical Case Series. (Han SJ, Teton Z, Gupta K, Kawamoto A, Raslan AM) Oper Neurosurg (Hagerstown) 2020 Sep 01;19(3):264-270       5 Citations
4Diffuse Midline Glioma With Osseous Metastases at Diagnosis: A Case Report. (Bhatt NS, Houser K, Belongia M, Ellison DW, Foy A, Jarzembowski J, Kelly T, Maheshwari M, Suchi M, Knipstein J) J Pediatr Hematol Oncol 2020 Oct;42(7):e673-e676       6 Citations
2Intravascular Papillary Endothelial Hyperplasia of the Pineal Region: A Case Report and Review of the Literature. (Retzlaff AA, Arispe K, Cochran EJ, Zwagerman NT) World Neurosurg 2020 Jan;133:308-313       7 Citations
1Pediatric Presurgical Functional MRI. (Maheshwari M) Top Magn Reson Imaging 2019 Aug;28(4):197-204       4 Citations
1Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial. (Schmainda KM, Prah MA, Zhang Z, Snyder BS, Rand SD, Jensen TR, Barboriak DP, Boxerman JL) AJNR Am J Neuroradiol 2019 Jul;40(7):1132-1139       15 Citations
4Intracranial Extraskeletal Mesenchymal Chondrosarcoma: Case Report and Review of the Literature of Reported Cases in Adults and Children. (Shabani S, Kaushal M, Kaufman B, Knipstein J, Lawlor MW, Lew S, Foy A) World Neurosurg 2019 Sep;129:302-310       6 Citations
4Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis. (Cheng G, Zhang Q, Pan J, Lee Y, Ouari O, Hardy M, Zielonka M, Myers CR, Zielonka J, Weh K, Chang AC, Chen G, Kresty L, Kalyanaraman B, You M) Nat Commun 2019 May 17;10(1):2205       146 Citations
2Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors. (Schmainda KM, Prah MA, Hu LS, Quarles CC, Semmineh N, Rand SD, Connelly JM, Anderies B, Zhou Y, Liu Y, Logan B, Stokes A, Baird G, Boxerman JL) AJNR Am J Neuroradiol 2019 Apr;40(4):626-633       32 Citations
2Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial. (Sun A, Hu C, Wong SJ, Gore E, Videtic G, Dutta S, Suntharalingam M, Chen Y, Gaspar LE, Choy H) JAMA Oncol 2019 Jun 01;5(6):847-855       49 Citations
1Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO). (Bell LC, Semmineh N, An H, Eldeniz C, Wahl R, Schmainda KM, Prah MA, Erickson BJ, Korfiatis P, Wu C, Sorace AG, Yankeelov TE, Rutledge N, Chenevert TL, Malyarenko D, Liu Y, Brenner A, Hu LS, Zhou Y, Boxerman JL, Yen YF, Kalpathy-Cramer J, Beers AL, Muzi M, Madhuranthakam AJ, Pinho M, Johnson B, Quarles CC) Tomography 2019 Mar;5(1):110-117       21 Citations
1Gliomas: survival differences between metropolitan and non-metropolitan counties. (Best B, Nguyen HS, Doan NB, Gelsomino M, Shabani S, Ahmadi Jazi G, Sadati M, Sheikh S, Adl FH, Taqi MA, Mortazavi MM) J Neurosurg Sci 2019 Apr;63(2):114-120       3 Citations
1Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients. (Bliss LA, Strong EA, Gamblin TC) J Surg Oncol 2019 Apr;119(5):623-628       5 Citations
1Cell-of-origin susceptibility to glioblastoma formation declines with neural lineage restriction. (Alcantara Llaguno S, Sun D, Pedraza AM, Vera E, Wang Z, Burns DK, Parada LF) Nat Neurosci 2019 Apr;22(4):545-555       88 Citations
1Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis. (Chiang JCH, Harreld JH, Tanaka R, Li X, Wen J, Zhang C, Boué DR, Rauch TM, Boyd JT, Chen J, Corbo JC, Bouldin TW, Elton SW, Liu LL, Schofield D, Lee SC, Bouffard JP, Georgescu MM, Dossani RH, Aguiar MA, Sances RA, Saad AG, Boop FA, Qaddoumi I, Ellison DW) Neuro Oncol 2019 Jun 10;21(6):800-808       40 Citations
2Ganglioglioma in a Survivor of Infantile Glioblastoma. (Scheuermann A, Belongia M, Lawlor MW, Suchi M, Kaufman B, Vasudevaraja V, Serrano J, Snuderl M, Knipstein J) J Pediatr Hematol Oncol 2020 Jan;42(1):e56-e60       2 Citations
1Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue. (Shuen AY, Lanni S, Panigrahi GB, Edwards M, Yu L, Campbell BB, Mandel A, Zhang C, Zhukova N, Alharbi M, Bernstein M, Bowers DC, Carroll S, Cole KA, Constantini S, Crooks B, Dvir R, Farah R, Hijiya N, George B, Laetsch TW, Larouche V, Lindhorst S, Luiten RC, Magimairajan V, Mason G, Mason W, Mordechai O, Mushtaq N, Nicholas G, Oren M, Palma L, Pedroza LA, Ramdas J, Samuel D, Wolfe Schneider K, Seeley A, Semotiuk K, Shamvil A, Sumerauer D, Toledano H, Tomboc P, Wierman M, Van Damme A, Lee YY, Zapotocky M, Bouffet E, Durno C, Aronson M, Gallinger S, Foulkes WD, Malkin D, Tabori U, Pearson CE) J Clin Oncol 2019 Feb 20;37(6):461-470       23 Citations
1Incidentally found brain tumors in the pediatric population: a case series and proposed treatment algorithm. (Wright E, Amankwah EK, Winesett SP, Tuite GF, Jallo G, Carey C, Rodriguez LF, Stapleton S) J Neurooncol 2019 Jan;141(2):355-361       14 Citations
1Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy. (Blessing MM, Blackburn PR, Balcom JR, Krishnan C, Harrod VL, Zimmermann MT, Barr Fritcher EG, Zysk CD, Jackson RA, Nair AA, Jenkins RB, Halling KC, Kipp BR, Ida CM) Acta Neuropathol Commun 2018 Nov 05;6(1):118       11 Citations
1Management and survival trends for adult patients with malignant gliomas in the setting of multiple primary tumors: a population based analysis. (Nguyen HS, Doan NB, Gelsomino M, Shabani S, Awad AJ, Kaushal M, Mortazavi MM) J Neurooncol 2019 Jan;141(1):213-221       4 Citations
1Identification of a panel of genes as a prognostic biomarker for glioblastoma. (Wang F, Zheng Z, Guan J, Qi D, Zhou S, Shen X, Wang F, Wenkert D, Kirmani B, Solouki T, Fonkem E, Wong ET, Huang JH, Wu E) EBioMedicine 2018 Nov;37:68-77       40 Citations
1Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order. (Bovi JA, Schultz CJ, Mehta MP, Corn BW) Int J Radiat Oncol Biol Phys 2018 Sep 01;102(1):59-60    
1Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial. (Bell EH, Zhang P, Fisher BJ, Macdonald DR, McElroy JP, Lesser GJ, Fleming J, Chakraborty AR, Liu Z, Becker AP, Fabian D, Aldape KD, Ashby LS, Werner-Wasik M, Walker EM, Bahary JP, Kwok Y, Yu HM, Laack NN, Schultz CJ, Gray HJ, Robins HI, Mehta MP, Chakravarti A) JAMA Oncol 2018 Oct 01;4(10):1405-1409       120 Citations
1Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance. (Nguyen HS, Shabani S, Awad AJ, Kaushal M, Doan N) Int J Mol Sci 2018 Jun 14;19(6)       39 Citations
2Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project. (Schmainda KM, Prah MA, Rand SD, Liu Y, Logan B, Muzi M, Rane SD, Da X, Yen YF, Kalpathy-Cramer J, Chenevert TL, Hoff B, Ross B, Cao Y, Aryal MP, Erickson B, Korfiatis P, Dondlinger T, Bell L, Hu L, Kinahan PE, Quarles CC) AJNR Am J Neuroradiol 2018 Jun;39(6):1008-1016       38 Citations
1Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes. (Hall WA, Pugh SL, Wefel JS, Armstrong TS, Gilbert MR, Brachman DG, Werner-Wasik M, Wendland MM, Brown PD, Chao ST, Roof KS, Robins HI, Mehta MP, Curran WJ Jr, Movsas B) Neurosurgery 2019 Jan 01;84(1):66-76       7 Citations
1NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. (Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ Jr) J Neurooncol 2018 Mar;137(1):39-47       27 Citations
1Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma. (Nizamutdinov D, Stock EM, Dandashi JA, Vasquez EA, Mao Y, Dayawansa S, Zhang J, Wu E, Fonkem E, Huang JH) World Neurosurg 2018 Jan;109:e67-e74       62 Citations
5Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics. (Prah MA, Al-Gizawiy MM, Mueller WM, Cochran EJ, Hoffmann RG, Connelly JM, Schmainda KM) J Neurooncol 2018 Jan;136(1):13-21       33 Citations
4Acid ceramidase confers radioresistance to glioblastoma cells. (Doan NB, Nguyen HS, Al-Gizawiy MM, Mueller WM, Sabbadini RA, Rand SD, Connelly JM, Chitambar CR, Schmainda KM, Mirza SP) Oncol Rep 2017 Oct;38(4):1932-1940       36 Citations
1Preventing Discontinuation of Radiation Therapy: Predictive Factors to Improve Patient Selection for Palliative Treatment. (Puckett LL, Luitweiler E, Potters L, Teckie S) J Oncol Pract 2017 Sep;13(9):e782-e791       11 Citations
1Optimization of DSC MRI Echo Times for CBV Measurements Using Error Analysis in a Pilot Study of High-Grade Gliomas. (Bell LC, Does MD, Stokes AM, Baxter LC, Schmainda KM, Dueck AC, Quarles CC) AJNR Am J Neuroradiol 2017 Sep;38(9):1710-1715       7 Citations
2Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937. (Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GMM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, Johnstone CA, Stieber VW, Paulus R, Bradley JD) J Thorac Oncol 2017 Oct;12(10):1561-1570       108 Citations
1Radiological diagnosis of drop metastases from paediatric brain tumours using combination of 2D and 3D MRI sequences. (Kralik SF, O'Neill DP, Kamer AP, Rodriguez E, Ho CY) Clin Radiol 2017 Oct;72(10):902.e13-902.e19       5 Citations
2Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report. (Khandelwal P, Millard HR, Thiel E, Abdel-Azim H, Abraham AA, Auletta JJ, Boulad F, Brown VI, Camitta BM, Chan KW, Chaudhury S, Cowan MJ, Angel-Diaz M, Gadalla SM, Gale RP, Hale G, Kasow KA, Keating AK, Kitko CL, MacMillan ML, Olsson RF, Page KM, Seber A, Smith AR, Warwick AB, Wirk B, Mehta PA) Biol Blood Marrow Transplant 2017 Aug;23(8):1342-1349       44 Citations
4Acid ceramidase is a novel drug target for pediatric brain tumors. (Doan NB, Nguyen HS, Montoure A, Al-Gizawiy MM, Mueller WM, Kurpad S, Rand SD, Connelly JM, Chitambar CR, Schmainda KM, Mirza SP) Oncotarget 2017 Apr 11;8(15):24753-24761       28 Citations
1Dysembryoplastic Neuroectodermal Tumor: An Analysis from the Surveillance, Epidemiology, and End Results Program, 2004-2013. (Nguyen HS, Doan N, Gelsomino M, Shabani S) World Neurosurg 2017 Jul;103:380-385       26 Citations
1Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis. (Costa R, Gill N, Rademaker AW, Carneiro BA, Chae YK, Kumthekar P, Gradishar WJ, Kurzrock R, Giles FJ) Cancer Treat Rev 2017 Apr;55:10-15       20 Citations
1Intracranial Subependymoma: A SEER Analysis 2004-2013. (Nguyen HS, Doan N, Gelsomino M, Shabani S) World Neurosurg 2017 May;101:599-605       29 Citations
1Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. (Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M) Neuro Oncol 2017 Feb 01;19(2):252-258       58 Citations
3Clinical experience with planning, quality assurance, and delivery of burst-mode modulated arc therapy. (Kainz K, Prah D, Ahunbay E, Li XA) J Appl Clin Med Phys 2016 Sep 08;17(5):47-59       1 Citation
1Glioblastoma Mimicking Meningioma: Report of 2 Cases. (Patel M, Nguyen HS, Doan N, Gelsomino M, Shabani S, Mueller W) World Neurosurg 2016 Nov;95:624.e9-624.e13       11 Citations
4Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma. (Nguyen HS, Milbach N, Hurrell SL, Cochran E, Connelly J, Bovi JA, Schultz CJ, Mueller WM, Rand SD, Schmainda KM, LaViolette PS) AJNR Am J Neuroradiol 2016 Dec;37(12):2201-2208       55 Citations
1Prophylactic cranial irradiation for patients with lung cancer. (Péchoux CL, Sun A, Slotman BJ, De Ruysscher D, Belderbos J, Gore EM) Lancet Oncol 2016 Jul;17(7):e277-e293       91 Citations
2Impact of Age at Diagnosis and Hypothalamic Involvement on Body Mass Index Z-Score Change in Pediatric Brain Tumor Survivors. (Strobel K, Simpson P, Donohoue PA, Firat S, Jogal S) Horm Res Paediatr 2016;85(6):389-95       1 Citation
1Health policy: The right to try is embodied in the right to die. (Cohen-Kurzrock BA, Cohen PR, Kurzrock R) Nat Rev Clin Oncol 2016 Jul;13(7):399-400       11 Citations
1ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI. (Gerstner ER, Zhang Z, Fink JR, Muzi M, Hanna L, Greco E, Prah M, Schmainda KM, Mintz A, Kostakoglu L, Eikman EA, Ellingson BM, Ratai EM, Sorensen AG, Barboriak DP, Mankoff DA, ACRIN 6684 Trial Group) Clin Cancer Res 2016 Oct 15;22(20):5079-5086       93 Citations
1Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain. (Divine LM, Kizer NT, Hagemann AR, Pittman ME, Chen L, Powell MA, Mutch DG, Rader JS, Thaker PH) Gynecol Oncol 2016 Jul;142(1):76-82       24 Citations
1Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. (Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ Jr) N Engl J Med 2016 Apr 07;374(14):1344-55       734 Citations
1Diffusion kurtosis imaging for cerebral astrocytomas. (Vedantam A, Rajshekhar V) Neurol India 2016;64(2):273-4    
1Flow-Related Aneurysm within Glioblastoma: A Case Report and Review of Literature. (Ene CI, Nerva JD, McGrath L, Flanagan ME, Chamberlain MC, Silbergeld DL) World Neurosurg 2016 May;89:729.e1-6       10 Citations
1Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes. (Alcantara Llaguno SR, Wang Z, Sun D, Chen J, Xu J, Kim E, Hatanpaa KJ, Raisanen JM, Burns DK, Johnson JE, Parada LF) Cancer Cell 2015 Oct 12;28(4):429-440       145 Citations
4Location of brain tumor intersecting white matter tracts predicts patient prognosis. (Mickevicius NJ, Carle AB, Bluemel T, Santarriaga S, Schloemer F, Shumate D, Connelly J, Schmainda KM, LaViolette PS) J Neurooncol 2015 Nov;125(2):393-400       24 Citations
1Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment. (Boxerman JL, Schmainda KM, Zhang Z, Barboriak DP) Neuro Oncol 2015 Nov;17(11):1538-9       6 Citations
2Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma. (Prah MA, Stufflebeam SM, Paulson ES, Kalpathy-Cramer J, Gerstner ER, Batchelor TT, Barboriak DP, Rosen BR, Schmainda KM) AJNR Am J Neuroradiol 2015 Sep;36(9):1654-61       40 Citations
4Photodynamic therapy (PDT) for malignant brain tumors--where do we stand? (Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, Lew SM, Girotti AW, Jogal S, LaViolette PS, Connelly JM, Whelan HT) Photodiagnosis Photodyn Ther 2015 Sep;12(3):530-44       168 Citations
1Sleep complaints in survivors of pediatric brain tumors. (Brimeyer C, Adams L, Zhu L, Srivastava DK, Wise M, Hudson MM, Crabtree VM) Support Care Cancer 2016 Jan;24(1):23-31       28 Citations
4Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. (Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS) J Neurooncol 2015 May;123(1):179-88       21 Citations
3Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma. (Elson A, Bovi J, Siker M, Schultz C, Paulson E) J Neurooncol 2015 May;122(3):549-58       28 Citations
1Usage of fMRI for pre-surgical planning in brain tumor and vascular lesion patients: task and statistical threshold effects on language lateralization. (Nadkarni TN, Andreoli MJ, Nair VA, Yin P, Young BM, Kundu B, Pankratz J, Radtke A, Holdsworth R, Kuo JS, Field AS, Baskaya MK, Moritz CH, Meyerand ME, Prabhakaran V) Neuroimage Clin 2015;7:415-23       33 Citations
1Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial. (Schmainda KM, Zhang Z, Prah M, Snyder BS, Gilbert MR, Sorensen AG, Barboriak DP, Boxerman JL) Neuro Oncol 2015 Aug;17(8):1148-56       97 Citations
3Preoperative diffusion tensor imaging: improving neurosurgical outcomes in brain tumor patients. (Ulmer JL, Klein AP, Mueller WM, DeYoe EA, Mark LP) Neuroimaging Clin N Am 2014 Nov;24(4):599-617       26 Citations
1Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma. (Hackett CS, Quigley DA, Wong RA, Chen J, Cheng C, Song YK, Wei JS, Pawlikowska L, Bao Y, Goldenberg DD, Nguyen K, Gustafson WC, Rallapalli SK, Cho YJ, Cook JM, Kozlov S, Mao JH, Van Dyke T, Kwok PY, Khan J, Balmain A, Fan Q, Weiss WA) Cell Rep 2014 Nov 06;9(3):1034-46       21 Citations
1Intratumoral Clostridium novyi as a potential treatment for solid necrotic brain tumors. (Zwagerman NT, Friedlander RM, Monaco EA 3rd) Neurosurgery 2014 Dec;75(6):N17-8       6 Citations
1Operative cytoreduction for recurrent glioblastoma. (Morton RP, Nerva JD, Abecassis IJ, Silbergeld DL, Kim LJ) World Neurosurg 2014 Dec;82(6):929-31    
1The biology of radiosurgery and its clinical applications for brain tumors. (Kondziolka D, Shin SM, Brunswick A, Kim I, Silverman JS) Neuro Oncol 2015 Jan;17(1):29-44       83 Citations
1ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases. (Expert Panel on Radiation Oncology-Brain Metastases, Lo SS, Gore EM, Bradley JD, Buatti JM, Germano I, Ghafoori AP, Henderson MA, Murad GJ, Patchell RA, Patel SH, Robbins JR, Robins HI, Vassil AD, Wippold FJ 2nd, Yunes MJ, Videtic GM) J Palliat Med 2014 Aug;17(8):880-6       26 Citations
1MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells. (Brower JV, Clark PA, Lyon W, Kuo JS) Neurochem Int 2014 Nov;77:68-77       73 Citations
6Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics. (Heroux MS, Chesnik MA, Halligan BD, Al-Gizawiy M, Connelly JM, Mueller WM, Rand SD, Cochran EJ, LaViolette PS, Malkin MG, Schmainda KM, Mirza SP) Physiol Genomics 2014 Jul 01;46(13):467-81       36 Citations
1Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. (Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, Wu Q, Flavahan W, Levison B, Johansen ML, Schmitt D, Neltner JM, Huang P, Ren B, Sloan AE, Silverstein RL, Gladson CL, DiDonato JA, Brown JM, McIntyre T, Hazen SL, Horbinski C, Rich JN, Lathia JD) Stem Cells 2014 Jul;32(7):1746-58       169 Citations
1Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus. (Piha-Paul SA, Shin SJ, Vats T, Guha-Thakurta N, Aaron J, Rytting M, Kleinerman E, Kurzrock R) Anticancer Res 2014 Apr;34(4):1939-45       24 Citations
1Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma. (Schmainda KM, Prah M, Connelly J, Rand SD, Hoffman RG, Mueller W, Malkin MG) Neuro Oncol 2014 Jun;16(6):880-8       103 Citations
3Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma. (LaViolette PS, Daun MK, Paulson ES, Schmainda KM) J Neurooncol 2014 Feb;116(3):543-549       8 Citations
1Reply: To PMID 23876864. (Ramasubramanian A, Meadows AT, Shields JA, Leahey A, Shields CL) Am J Ophthalmol 2013 Dec;156(6):1320-1       2 Citations
1A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. (Harter DH, Bassani L, Rodgers SD, Roth J, Devinsky O, Carlson C, Wisoff JH, Weiner HL) J Neurosurg Pediatr 2014 Jan;13(1):21-8       27 Citations
1Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer. (Falchook GS, Moulder SL, Wheler JJ, Jiang Y, Bastida CC, Kurzrock R) Ann Oncol 2013 Dec;24(12):3004-11       26 Citations
1Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. (Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, Tzuk-Shina T, Brown PD, Chakravarti A, Curran WJ Jr, Mehta MP) J Clin Oncol 2013 Nov 10;31(32):4085-91       759 Citations
1Semiautomated volumetric measurement on postcontrast MR imaging for analysis of recurrent and residual disease in glioblastoma multiforme. (Chow DS, Qi J, Guo X, Miloushev VZ, Iwamoto FM, Bruce JN, Lassman AB, Schwartz LH, Lignelli A, Zhao B, Filippi CG) AJNR Am J Neuroradiol 2014 Mar;35(3):498-503       56 Citations
1Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. (Smith EC, Blanc H, Surdel MC, Vignuzzi M, Denison MR) PLoS Pathog 2013 Aug;9(8):e1003565       312 Citations
1Diffusion-weighted MRI as a biomarker for treatment response in glioma. (Schmainda KM) CNS Oncol 2012 Nov;1(2):169-80       44 Citations
2Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression. (Mammoto T, Jiang A, Jiang E, Panigrahy D, Kieran MW, Mammoto A) Am J Pathol 2013 Oct;183(4):1293-1305       125 Citations
1Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era. (Ramasubramanian A, Kytasty C, Meadows AT, Shields JA, Leahey A, Shields CL) Am J Ophthalmol 2013 Oct;156(4):825-9       34 Citations
3The role of pre-treatment white matter abnormalities in developing white matter changes following whole brain radiation: a volumetric study. (Sabsevitz DS, Bovi JA, Leo PD, Laviolette PS, Rand SD, Mueller WM, Schultz CJ) J Neurooncol 2013 Sep;114(3):291-7       10 Citations
1Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels. (Bozdag S, Li A, Riddick G, Kotliarov Y, Baysan M, Iwamoto FM, Cam MC, Kotliarova S, Fine HA) PLoS One 2013;8(4):e62982       48 Citations
1Brain metastasis from oesophageal adenocarcinoma. (Nwankwo N, Mirrakhimov AE, Wind KP, Bucher N) BMJ Case Rep 2013 Apr 19;2013       1 Citation
1Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. (Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, Werner-Wasik M, Sun AY, Choy H, Movsas B) Int J Radiat Oncol Biol Phys 2013 Jul 15;86(4):656-64       157 Citations
2Association of functional magnetic resonance imaging indices with postoperative language outcomes in patients with primary brain tumors. (Kundu B, Penwarden A, Wood JM, Gallagher TA, Andreoli MJ, Voss J, Meier T, Nair VA, Kuo JS, Field AS, Moritz C, Meyerand ME, Prabhakaran V) Neurosurg Focus 2013 Apr;34(4):E6       34 Citations
1The role of secondary motor and language cortices in morbidity and mortality: a retrospective functional MRI study of surgical planning for patients with intracranial tumors. (Voss J, Meier TB, Freidel R, Kundu B, Nair VA, Holdsworth R, Kuo JS, Prabhakaran V) Neurosurg Focus 2013 Apr;34(4):E7       19 Citations
1Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases. (Prabhu RS, Dhabaan A, Hall WA, Ogunleye T, Crocker I, Curran WJ, Shu HK) J Neurooncol 2013 May;113(1):93-9       20 Citations
2The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications. (Boxerman JL, Paulson ES, Prah MA, Schmainda KM) AJNR Am J Neuroradiol 2013 Jul;34(7):1364-9       32 Citations
4Effects of perfusion on diffusion changes in human brain tumors. (Cohen AD, LaViolette PS, Prah M, Connelly J, Malkin MG, Rand SD, Mueller WM, Schmainda KM) J Magn Reson Imaging 2013 Oct;38(4):868-75       6 Citations
4Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma. (LaViolette PS, Cohen AD, Prah MA, Rand SD, Connelly J, Malkin MG, Mueller WM, Schmainda KM) Neuro Oncol 2013 Apr;15(4):442-50       40 Citations
1Strategies to maximize resection of complex, or high surgical risk, low-grade gliomas. (Wilden JA, Voorhies J, Mosier KM, O'Neill DP, Cohen-Gadol AA) Neurosurg Focus 2013 Feb;34(2):E5       24 Citations
1SWI/SNF gene variants and glioma risk and outcome. (Amankwah EK, Thompson RC, Nabors LB, Olson JJ, Browning JE, Madden MH, Egan KM) Cancer Epidemiol 2013 Apr;37(2):162-5       12 Citations
1Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey. (Komaki R, Khalid N, Langer CJ, Kong FM, Owen JB, Crozier CL, Wilson JF, Wei X, Movsas B) Int J Radiat Oncol Biol Phys 2013 Mar 15;85(4):1082-9       46 Citations
1RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. (Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP, Bredel M, Mehta M) Int J Radiat Oncol Biol Phys 2013 Apr 01;85(5):1206-11       119 Citations
1G-cimp status prediction of glioblastoma samples using mRNA expression data. (Baysan M, Bozdag S, Cam MC, Kotliarova S, Ahn S, Walling J, Killian JK, Stevenson H, Meltzer P, Fine HA) PLoS One 2012;7(11):e47839       32 Citations
1Melanoma brain metastasis: overview of current management and emerging targeted therapies. (Fonkem E, Uhlmann EJ, Floyd SR, Mahadevan A, Kasper E, Eton O, Wong ET) Expert Rev Neurother 2012 Oct;12(10):1207-15       64 Citations
1NovoTTF-100A: a new treatment modality for recurrent glioblastoma. (Fonkem E, Wong ET) Expert Rev Neurother 2012 Aug;12(8):895-9       56 Citations
1Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. (Falchook GS, Long GV, Kurzrock R, Kim KB, Arkenau TH, Brown MP, Hamid O, Infante JR, Millward M, Pavlick AC, O'Day SJ, Blackman SC, Curtis CM, Lebowitz P, Ma B, Ouellet D, Kefford RF) Lancet 2012 May 19;379(9829):1893-901       799 Citations
1ACR Appropriateness Criteria® follow-up and retreatment of brain metastases. (Patel SH, Robbins JR, Gore EM, Bradley JD, Gaspar LE, Germano I, Ghafoori P, Henderson MA, Lutz ST, McDermott MW, Patchell RA, Robins HI, Vassil AD, Wippold FJ 2nd, Videtic GM, Expert Panel on Radiation Oncology–Brain Metastases) Am J Clin Oncol 2012 Jun;35(3):302-6       26 Citations
1Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastoma. (Huang P, Rani MR, Ahluwalia MS, Bae E, Prayson RA, Weil RJ, Nowacki AS, Hedayat H, Sloan AE, Lathia JD, Rich JN, Tipps R, Gladson CL) Cancer Res 2012 Mar 15;72(6):1428-37       34 Citations
3The Role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. (Boxerman JL, Prah DE, Paulson ES, Machan JT, Bedekar D, Schmainda KM) AJNR Am J Neuroradiol 2012 Jun;33(6):1081-7       97 Citations
2Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume. (Pechman KR, Donohoe DL, Bedekar DP, Kurpad SN, Schmainda KM) Magn Reson Med 2012 Oct;68(4):1266-72       6 Citations
1Rare phenomenon of extracranial metastasis of glioblastoma. (Fonkem E, Lun M, Wong ET) J Clin Oncol 2011 Dec 01;29(34):4594-5       29 Citations
1Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI. (Budde MD, Gold E, Jordan EK, Frank JA) Clin Exp Metastasis 2012 Jan;29(1):51-62       25 Citations
1Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain. (Budde MD, Gold E, Jordan EK, Smith-Brown M, Frank JA) NMR Biomed 2012 May;25(5):726-36       15 Citations
1An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. (Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, Féau C, Phoenix T, Gibson P, Zhu L, Tong Y, Eden C, Ellison DW, Priebe W, Koul D, Yung WK, Gajjar A, Stewart CF, Guy RK, Gilbertson RJ) Cancer Cell 2011 Sep 13;20(3):384-99       93 Citations
1Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab. (Ellingson BM, Cloughesy TF, Lai A, Mischel PS, Nghiemphu PL, Lalezari S, Schmainda KM, Pope WB) Neuro Oncol 2011 Oct;13(10):1151-61       68 Citations
1Case report: are clinicians obligated to medically treat a suicide attempt in a patient with a prognosis of weeks? (Marks S, Heinrich TW, Rosielle D) J Palliat Med 2012 Jan;15(1):134-7       4 Citations
1Temporal lobe pleomorphic xanthoastrocytoma and chronic epilepsy: long-term surgical outcomes. (Wallace DJ, Byrne RW, Ruban D, Cochran EJ, Roh D, Whisler WW) Clin Neurol Neurosurg 2011 Dec;113(10):918-22       14 Citations
1Prognostic value of H-MLH1 after adjusting for RPA class in GBM patients. (Choucair A, Moughan J, Schultz C, Schulsinger A, Mehta M, Curran W) Front Biosci (Elite Ed) 2011 Jun 01;3(3):1182-91       2 Citations
1Improvement of survival and prospect of cure in patients with metastatic breast cancer. (Cheng YC, Ueno NT) Breast Cancer 2012 Jul;19(3):191-9       57 Citations
2Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume. (Pechman KR, Donohoe DL, Bedekar DP, Kurpad SN, Hoffmann RG, Schmainda KM) J Neurooncol 2011 Nov;105(2):233-9       17 Citations
1Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trial. (McHaffie DR, Chabot P, Dagnault A, Suh JH, Fortin MA, Chang E, Timmerman R, Souhami L, Grecula J, Nabid A, Schultz C, Werner-Wasik M, Gaspar LE, Brachman D, Mody T, Mehta MP) J Neurooncol 2011 Nov;105(2):301-8       15 Citations
1Microwave beamforming for non-invasive patient-specific hyperthermia treatment of pediatric brain cancer. (Burfeindt MJ, Zastrow E, Hagness SC, Van Veen BD, Medow JE) Phys Med Biol 2011 May 07;56(9):2743-54       45 Citations
1Phase I clinical trial outcomes in 93 patients with brain metastases: the MD anderson cancer center experience. (Tsimberidou AM, Letourneau K, Wen S, Wheler J, Hong D, Naing A, Iskander NG, Uehara C, Kurzrock R) Clin Cancer Res 2011 Jun 15;17(12):4110-8       21 Citations
4Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI. (Ellingson BM, LaViolette PS, Rand SD, Malkin MG, Connelly JM, Mueller WM, Prost RW, Schmainda KM) Magn Reson Med 2011 Apr;65(4):1131-43       38 Citations
3Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study. (Siker ML, Firat SY, Mueller W, Krouwer H, Schultz CJ) Int J Radiat Oncol Biol Phys 2012 Feb 01;82(2):765-72       6 Citations
1Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison. (Siker ML, Wang M, Porter K, Nelson DF, Curran WJ, Michalski JM, Souhami L, Chakravarti A, Yung WK, Delrowe J, Coughlin CT, Mehta MP) J Neurooncol 2011 Aug;104(1):351-6       32 Citations
1Time-multiplexed beamforming for noninvasive microwave hyperthermia treatment. (Zastrow E, Hagness SC, Van Veen BD, Medow JE) IEEE Trans Biomed Eng 2011 Jun;58(6):1574-84       47 Citations
2Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. (Sun A, Bae K, Gore EM, Movsas B, Wong SJ, Meyers CA, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):279-86       304 Citations
2Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. (Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H) J Clin Oncol 2011 Jan 20;29(3):272-8       249 Citations
1Stereotactic radiosurgery for the management of brain metastases. (Choong NW, Gore E) N Engl J Med 2010 Aug 05;363(6):592; author reply 592-3    
4Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas. (Ellingson BM, Malkin MG, Rand SD, LaViolette PS, Connelly JM, Mueller WM, Schmainda KM) J Neurooncol 2011 Mar;102(1):95-103       56 Citations
1Response of histiocytoses to imatinib mesylate: fire to ashes. (Janku F, Amin HM, Yang D, Garrido-Laguna I, Trent JC, Kurzrock R) J Clin Oncol 2010 Nov 01;28(31):e633-6       74 Citations
1Epstein-Barr virus-associated intracranial leiomyosarcoma in an HIV-positive adolescent. (Gupta S, Havens PL, Southern JF, Firat SY, Jogal SS) J Pediatr Hematol Oncol 2010 May;32(4):e144-7       31 Citations
3Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. (Ellingson BM, Malkin MG, Rand SD, Connelly JM, Quinsey C, LaViolette PS, Bedekar DP, Schmainda KM) J Magn Reson Imaging 2010 Mar;31(3):538-48       213 Citations
1Lovenox hurts. (Jaglowski SM) Ann Intern Med 2009 Oct 20;151(8):585-6    
1Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. (Hu LS, Baxter LC, Pinnaduwage DS, Paine TL, Karis JP, Feuerstein BG, Schmainda KM, Dueck AC, Debbins J, Smith KA, Nakaji P, Eschbacher JM, Coons SW, Heiserman JE) AJNR Am J Neuroradiol 2010 Jan;31(1):40-8       125 Citations
1Computer-aided detection of brain tumor invasion using multiparametric MRI. (Jensen TR, Schmainda KM) J Magn Reson Imaging 2009 Sep;30(3):481-9       32 Citations
1Chronic epilepsy associated with temporal tumors: long-term surgical outcome. (Ruban D, Byrne RW, Kanner A, Smith M, Cochran EJ, Roh D, Whisler WW) Neurosurg Focus 2009 Aug;27(2):E6       28 Citations
2Peripheral cysts: a distinguishing feature of esthesioneuroblastoma with intracranial extension. (Tseng J, Michel MA, Loehrl TA) Ear Nose Throat J 2009 Jun;88(6):E14       10 Citations
1Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. (Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S) Pediatrics 2009 Mar;123(3):1011-7       46 Citations
1Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism. (Kaur B, Cork SM, Sandberg EM, Devi NS, Zhang Z, Klenotic PA, Febbraio M, Shim H, Mao H, Tucker-Burden C, Silverstein RL, Brat DJ, Olson JJ, Van Meir EG) Cancer Res 2009 Feb 01;69(3):1212-20       91 Citations
1p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor. (Saab R, Rodriguez-Galindo C, Matmati K, Rehg JE, Baumer SH, Khoury JD, Billups C, Neale G, Helton KJ, Skapek SX) Cancer Res 2009 Jan 15;69(2):440-8       21 Citations
1Vessel microport technique for applications in cerebrovascular research. (Chen L, Swartz KR, Toborek M) J Neurosci Res 2009 May 15;87(7):1718-27       33 Citations
2Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. (Paulson ES, Schmainda KM) Radiology 2008 Nov;249(2):601-13       273 Citations
1Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. (Vogelbaum MA, Berkey B, Peereboom D, Macdonald D, Giannini C, Suh JH, Jenkins R, Herman J, Brown P, Blumenthal DT, Biggs C, Schultz C, Mehta M) Neuro Oncol 2009 Apr;11(2):167-75       61 Citations
1Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib. (Braiteh F, Kurzrock R, Johnson FM) J Clin Oncol 2008 Jul 10;26(20):3460-2       37 Citations
1Brain metastases in very young patients with lung cancer are still brain metastases. (Gore EM) Onkologie 2008 Jun;31(6):297-8       1 Citation
1Protocol for the examination of specimens from patients with tumors of the brain/spinal cord. (Parisi JE, Miller DV, Boyer PJ, Brat DJ, Cochran EJ, Cohen ML, Demasters BK, Dolinak D, McComb RD, McLendon RE, Powell SZ, Prayson RA, Vinters HV, Yachnis AT, Members of Cancer Committee, College of American Pathologists) Arch Pathol Lab Med 2008 Jun;132(6):907-12       6 Citations
1The superior longitudinal fasciculus and speech arrest. (Davtian M, Ulmer JL, Mueller WM, Gaggl W, Mulane MP, Krouwer HG) J Comput Assist Tomogr 2008;32(3):410-4       16 Citations
1Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. (Muscal JA, Jones JY, Paulino AC, Bertuch AA, Su J, Woo SY, Mahoney DH Jr, Chintagumpala M) Int J Radiat Oncol Biol Phys 2009 Jan 01;73(1):214-21       15 Citations
1Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. (Perry A, Miller CR, Gujrati M, Scheithauer BW, Zambrano SC, Jost SC, Raghavan R, Qian J, Cochran EJ, Huse JT, Holland EC, Burger PC, Rosenblum MK) Brain Pathol 2009 Jan;19(1):81-90       147 Citations
1Radiation for brain metastases. (Siker ML, Mehta MP) Cancer Treat Res 2007;136:91-115       2 Citations
1The influence of caregiver mastery on depressive symptoms. (Sherwood PR, Given BA, Given CW, Schiffman RF, Murman DL, von Eye A, Lovely M, Rogers LR, Remer S) J Nurs Scholarsh 2007;39(3):249-55       53 Citations
1Local epileptogenic networks in tuberous sclerosis complex: a case review. (Madhavan D, Weiner HL, Carlson C, Devinsky O, Kuzniecky R) Epilepsy Behav 2007 Aug;11(1):140-6       33 Citations
3Development of an inverse optimization package to plan nonuniform dose distributions based on spatially inhomogeneous radiosensitivity extracted from biological images. (Chen GP, Ahunbay E, Schultz C, Li XA) Med Phys 2007 Apr;34(4):1198-205       22 Citations
1Environmental risk factors for brain tumors. (Connelly JM, Malkin MG) Curr Neurol Neurosci Rep 2007 May;7(3):208-14       69 Citations
1Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI. (Quarles CC, Schmainda KM) Magn Reson Med 2007 Apr;57(4):680-7       39 Citations
1Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors. (Martin DT, Gendron RL, Jarzembowski JA, Perry A, Collins MH, Pushpanathan C, Miskiewicz E, Castle VP, Paradis H) Clin Cancer Res 2007 Mar 01;13(5):1480-7       13 Citations
3Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. (Li XA, Qi XS, Pitterle M, Kalakota K, Mueller K, Erickson BA, Wang D, Schultz CJ, Firat SY, Wilson JF) Int J Radiat Oncol Biol Phys 2007 Jun 01;68(2):581-91       108 Citations
1Resection versus radiosurgery for patients with brain metastases. (Siker ML, Mehta MP) Future Oncol 2007 Feb;3(1):95-102       14 Citations
1Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? (Siker ML, Chakravarti A, Mehta MP) Crit Rev Oncol Hematol 2006 Nov;60(2):99-111       31 Citations
1Focal cerebral pathology presenting as tonic seizures. (Patel H, Smith J, Garg B) J Child Neurol 2006 Sep;21(9):813-6       4 Citations
1Water diffusion heterogeneity index in the human brain is insensitive to the orientation of applied magnetic field gradients. (Bennett KM, Hyde JS, Schmainda KM) Magn Reson Med 2006 Aug;56(2):235-9       78 Citations
1Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710. (Colman H, Berkey BA, Maor MH, Groves MD, Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK, Radiation Therapy Oncology Group) Int J Radiat Oncol Biol Phys 2006 Nov 01;66(3):818-24       48 Citations
1Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. (Boxerman JL, Schmainda KM, Weisskoff RM) AJNR Am J Neuroradiol 2006 Apr;27(4):859-67       584 Citations
1An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor. (Qi XS, Schultz CJ, Li XA) Int J Radiat Oncol Biol Phys 2006 Apr 01;64(5):1570-80       44 Citations
1Presurgical and intraoperative mapping of the motor system in congenital truncation of the precentral gyrus. (Salvan CV, Ulmer JL, Mueller WM, Krouwer HG, Prost RW, Stroe GO) AJNR Am J Neuroradiol 2006 Mar;27(3):493-7       9 Citations
1Predictors of distress in caregivers of persons with a primary malignant brain tumor. (Sherwood PR, Given BA, Given CW, Schiffman RF, Murman DL, Lovely M, von Eye A, Rogers LR, Remer S) Res Nurs Health 2006 Apr;29(2):105-20       129 Citations
1Prophylactic cranial irradiation versus observation in stage III non-small-cell lung cancer. (Gore E) Clin Lung Cancer 2006 Jan;7(4):276-8       4 Citations
1Imaging characteristics and growth of subependymal giant cell astrocytomas. (Clarke MJ, Foy AB, Wetjen N, Raffel C) Neurosurg Focus 2006 Jan 15;20(1):E5       44 Citations
1Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. (Robins HI, Won M, Seiferheld WF, Schultz CJ, Choucair AK, Brachman DG, Demas WF, Mehta MP) Neuro Oncol 2006 Jan;8(1):47-52       56 Citations
1RTOG 0214: a phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer. (Gore E) Clin Adv Hematol Oncol 2005 Aug;3(8):625-6       12 Citations
1Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation. (Quarles CC, Ward BD, Schmainda KM) Magn Reson Med 2005 Jun;53(6):1307-16       67 Citations
1Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters. (Quarles CC, Krouwer HG, Rand SD, Schmainda KM) Technol Cancer Res Treat 2005 Jun;4(3):245-9       16 Citations
1Resolution and contrast in magnetic resonance electrical impedance tomography (MREIT) and its application to cancer imaging. (Muftuler LT, Hamamura M, Birgul O, Nalcioglu O) Technol Cancer Res Treat 2004 Dec;3(6):599-609       63 Citations
1The role of diffusion tensor imaging in establishing the proximity of tumor borders to functional brain systems: implications for preoperative risk assessments and postoperative outcomes. (Ulmer JL, Salvan CV, Mueller WM, Krouwer HG, Stroe GO, Aralasmak A, Prost RW) Technol Cancer Res Treat 2004 Dec;3(6):567-76       83 Citations
1Non-small cell lung cancer and central nervous system metastases: should we be using prophylactic cranial irradiation? (Gore E, Choy H) Semin Radiat Oncol 2004 Oct;14(4):292-7       12 Citations
1Intravoxel distribution of DWI decay rates reveals C6 glioma invasion in rat brain. (Bennett KM, Hyde JS, Rand SD, Bennett R, Krouwer HG, Rebro KJ, Schmainda KM) Magn Reson Med 2004 Nov;52(5):994-1004       56 Citations
1Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. (Schmainda KM, Rand SD, Joseph AM, Lund R, Ward BD, Pathak AP, Ulmer JL, Badruddoja MA, Krouwer HG) AJNR Am J Neuroradiol 2004 Oct;25(9):1524-32       179 Citations
4Lesion-induced pseudo-dominance at functional magnetic resonance imaging: implications for preoperative assessments. (Ulmer JL, Hacein-Bey L, Mathews VP, Mueller WM, DeYoe EA, Prost RW, Meyer GA, Krouwer HG, Schmainda KM) Neurosurgery 2004 Sep;55(3):569-79; discussion 580-1       171 Citations
1Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery. (Vavra M, Ali MJ, Kang EW, Navalitloha Y, Ebert A, Allen CV, Groothuis DR) Neuro Oncol 2004 Apr;6(2):104-12       37 Citations
1Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. (Regine WF, Schmitt FA, Scott CB, Dearth C, Patchell RA, Nichols RC Jr, Gore EM, Franklin RL 3rd, Suh JH, Mehta MP) Int J Radiat Oncol Biol Phys 2004 Apr 01;58(5):1346-52       71 Citations
1Caregivers of persons with a brain tumor: a conceptual model. (Sherwood P, Given B, Given C, Schiffman R, Murman D, Lovely M) Nurs Inq 2004 Mar;11(1):43-53       80 Citations
2Visual object agnosia and pure word alexia: correlation of functional magnetic resonance imaging and lesion localization. (Salvan CV, Ulmer JL, DeYoe EA, Wascher T, Mathews VP, Lewis JW, Prost RW) J Comput Assist Tomogr 2004;28(1):63-7       22 Citations
1Dexmedetomidine and neurocognitive testing in awake craniotomy. (Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien CA) J Neurosurg Anesthesiol 2004 Jan;16(1):20-5       130 Citations
1Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. (Badruddoja MA, Krouwer HG, Rand SD, Rebro KJ, Pathak AP, Schmainda KM) Neuro Oncol 2003 Oct;5(4):235-43       61 Citations
1The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2*) and contrast agent (MION) dose. (Pathak AP, Rand SD, Schmainda KM) J Magn Reson Imaging 2003 Oct;18(4):397-403       40 Citations
1Noninvasive assessment of neoplastic angiogenesis: the role of magnetic resonance imaging. (Abu-Hajir M, Rand SD, Krouwer HG, Schmainda KM) Semin Thromb Hemost 2003 Jun;29(3):309-15       6 Citations
1Prophylactic cranial irradiation for patients with locally advanced non-small-cell lung cancer. (Gore EM) Oncology (Williston Park) 2003 Jun;17(6):775-9; discussion 779-80, 784, 787 passim       9 Citations
1Spin traps: in vitro toxicity and stability of radical adducts. (Khan N, Wilmot CM, Rosen GM, Demidenko E, Sun J, Joseph J, O'Hara J, Kalyanaraman B, Swartz HM) Free Radic Biol Med 2003 Jun 01;34(11):1473-81       111 Citations
1Pseudo-reorganization of language cortical function at fMR imaging: a consequence of tumor-induced neurovascular uncoupling. (Ulmer JL, Krouwer HG, Mueller WM, Ugurel MS, Kocak M, Mark LP) AJNR Am J Neuroradiol 2003 Feb;24(2):213-7       117 Citations
1Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. (DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ, Radiation Therapy Oncology Group Study 93-10) J Clin Oncol 2002 Dec 15;20(24):4643-8       623 Citations
1Oligodendroglioma: pathology and molecular biology. (Engelhard HH, Stelea A, Cochran EJ) Surg Neurol 2002 Aug;58(2):111-7; discussion 117       76 Citations
1Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. (Mehta MP, Shapiro WR, Glantz MJ, Patchell RA, Weitzner MA, Meyers CA, Schultz CJ, Roa WH, Leibenhaut M, Ford J, Curran W, Phan S, Smith JA, Miller RA, Renschler MF) J Clin Oncol 2002 Aug 15;20(16):3445-53       134 Citations
1Water exchange and inflow affect the accuracy of T1-GRE blood volume measurements: implications for the evaluation of tumor angiogenesis. (Kim YR, Rebro KJ, Schmainda KM) Magn Reson Med 2002 Jun;47(6):1110-20       57 Citations
1Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. (Regine WF, Huhn JL, Patchell RA, St Clair WH, Strottmann J, Meigooni A, Sanders M, Young AB) Int J Radiat Oncol Biol Phys 2002 Feb 01;52(2):333-8       183 Citations
1An unusual cystic appearance of disseminated low-grade gliomas. (Huang T, Zimmerman RA, Perilongo G, Kaufman BA, Holden KR, Carollo C, Chong WK) Neuroradiology 2001 Oct;43(10):868-74       22 Citations
1MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. (Pathak AP, Schmainda KM, Ward BD, Linderman JR, Rebro KJ, Greene AS) Magn Reson Med 2001 Oct;46(4):735-47       111 Citations
1Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. (Gauvain KM, McKinstry RC, Mukherjee P, Perry A, Neil JJ, Kaufman BA, Hayashi RJ) AJR Am J Roentgenol 2001 Aug;177(2):449-54       327 Citations
1Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study. (Regine WF, Patchell RA, Strottmann JM, Meigooni A, Sanders M, Young B) J Neurosurg 2000 Dec;93 Suppl 3:37-41       18 Citations
1The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme. (Gamburg ES, Regine WF, Patchell RA, Strottmann JM, Mohiuddin M, Young AB) Int J Radiat Oncol Biol Phys 2000 Dec 01;48(5):1359-62       34 Citations
1fMRI for preoperative neurosurgical mapping of motor cortex and language in a clinical setting. (Tomczak RJ, Wunderlich AP, Wang Y, Braun V, Antoniadis G, Görich J, Richter HP, Brambs HJ) J Comput Assist Tomogr 2000;24(6):927-34       61 Citations
1Preliminary report of a phase I study of combined fractionated stereotactic radiosurgery and conventional external beam radiation therapy for unfavorable gliomas. (Regine WF, Patchell RA, Strottmann JM, Meigooni A, Sanders M, Young AB) Int J Radiat Oncol Biol Phys 2000 Sep 01;48(2):421-6       17 Citations
1Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model. (Butzen J, Prost R, Chetty V, Donahue K, Neppl R, Bowen W, Li SJ, Haughton V, Mark L, Kim T, Mueller W, Meyer G, Krouwer H, Rand S) AJNR Am J Neuroradiol 2000 Aug;21(7):1213-9       51 Citations
1Giant anterior communicating artery aneurysm infiltrated with a primary cerebral lymphoma: case report. (Roitberg BZ, Cochran EJ, Thornton J, Charbel FT) Neurosurgery 2000 Aug;47(2):458-62       16 Citations
1Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. (Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalkowski CS, Censky SC, Prost RW) Magn Reson Med 2000 Jun;43(6):845-53       212 Citations
1Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression. (Khoshyomn S, Lew S, DeMattia J, Singer EB, Penar PL) J Neurooncol 1999;45(2):111-6       25 Citations
2Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier. (Muthian S, Nithipatikom K, Campbell WB, Hillard CJ) J Pharmacol Exp Ther 2000 Apr;293(1):289-95       33 Citations
1Comparison of fMRI and intraoperative direct cortical stimulation in localization of receptive language areas. (Lurito JT, Lowe MJ, Sartorius C, Mathews VP) J Comput Assist Tomogr 2000;24(1):99-105       97 Citations
1Contrast issues in brain tumor imaging. (Abdullah ND, Mathews VP) Neuroimaging Clin N Am 1999 Nov;9(4):733-49       12 Citations
1Mortality among chemical plant workers exposed to acrylonitrile and other substances. (Marsh GM, Gula MJ, Youk AO, Schall LC) Am J Ind Med 1999 Oct;36(4):423-36       18 Citations
1Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. (Jakacki RI, Jamison C, Mathews VP, Heilman DK, Dropcho E, Cornetta K, Macdonald DR, Williams DA) Med Pediatr Oncol 1998 Dec;31(6):483-90       20 Citations
2Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. (Krouwer HG, Kim TA, Rand SD, Prost RW, Haughton VM, Ho KC, Jaradeh SS, Meyer GA, Blindauer KA, Cusick JF, Morris GL, Walsh PR) AJNR Am J Neuroradiol 1998 Oct;19(9):1695-703       68 Citations
1Intracranial tumor in children: MR imaging findings within 24 hours of craniotomy. (Oser AB, Moran CJ, Kaufman BA, Park TS) Radiology 1997 Dec;205(3):807-12       41 Citations
1Stereotactic transsylvian, transinsular approach for deep-seated lesions. (Heffez DS) Surg Neurol 1997 Aug;48(2):113-24       32 Citations
2Functional MR activation correlated with intraoperative cortical mapping. (Yetkin FZ, Mueller WM, Morris GL, McAuliffe TL, Ulmer JL, Cox RW, Daniels DL, Haughton VM) AJNR Am J Neuroradiol 1997 Aug;18(7):1311-5       225 Citations
1Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. (Kurpad SN, Dolan ME, McLendon RE, Archer GE, Moschel RC, Pegg AE, Bigner DD, Friedman HS) Cancer Chemother Pharmacol 1997;39(4):307-16       30 Citations
1Effects of contrast dose, delayed imaging, and magnetization transfer saturation on gadolinium-enhanced MR imaging of brain lesions. (Mathews VP, Caldemeyer KS, Ulmer JL, Nguyen H, Yuh WT) J Magn Reson Imaging 1997;7(1):14-22       43 Citations
1Radiation-induced cerebral osteogenic sarcoma. (Smith MM, Thompson JE, Castillo M) AJR Am J Roentgenol 1996 Oct;167(4):1067       5 Citations
2Functional magnetic resonance imaging mapping of the motor cortex in patients with cerebral tumors. (Mueller WM, Yetkin FZ, Hammeke TA, Morris GL 3rd, Swanson SJ, Reichert K, Cox R, Haughton VM) Neurosurgery 1996 Sep;39(3):515-20; discussion 520-1       227 Citations
1MR of recurrent high-grade astrocytomas after intralesional immunotherapy. (Smith MM, Thompson JE, Castillo M, Cush S, Mukherji SK, Miller CH, Quattrocchi KB) AJNR Am J Neuroradiol 1996;17(6):1065-71       42 Citations
1Metastatic Wilm's tumor to the central nervous system. Extraosseous accumulation of bone seeking radiopharmaceutical. (Sty JR, Wells RG, Gregg DC) Clin Nucl Med 1996 May;21(5):410-1    
1Magnetization transfer or spin-lock? An investigation of off-resonance saturation pulse imaging with varying frequency offsets. (Ulmer JL, Mathews VP, Hamilton CA, Elster AD, Moran PR) AJNR Am J Neuroradiol 1996 May;17(5):805-19       59 Citations
1Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis. (Pahapill PA, Ramsay DA, Del Maestro RF) Neurosurgery 1996 Apr;38(4):822-8; discussion 828-9       95 Citations
1Demonstration of a brachytherapy boost dose-response relationship in glioblastoma multiforme: headed in the right direction. (Schultz CJ) Int J Radiat Oncol Biol Phys 1996 Apr 01;35(1):187-8    
1A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. (Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP) Int J Radiat Oncol Biol Phys 1996 Apr 01;35(1):27-35       454 Citations
1MR perfusion studies with T1-weighted echo planar imaging. (Kwong KK, Chesler DA, Weisskoff RM, Donahue KM, Davis TL, Ostergaard L, Campbell TA, Rosen BR) Magn Reson Med 1995 Dec;34(6):878-87       413 Citations
1Tumor antigens in astrocytic gliomas. (Kurpad SN, Zhao XG, Wikstrand CJ, Batra SK, McLendon RE, Bigner DD) Glia 1995 Nov;15(3):244-56       107 Citations
1Location of the sensorimotor cortex: functional and conventional MR compared. (Yetkin FZ, Papke RA, Mark LP, Daniels DL, Mueller WM, Haughton VM) AJNR Am J Neuroradiol 1995;16(10):2109-13       53 Citations
1Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats. (Kurpad SN, Friedman HS, Archer GE, McLendon RE, Petros WM, Fuchs HE, Guaspari A, Bigner DD) Cancer Res 1995 Sep 01;55(17):3803-9       11 Citations
1Spinal magnetic resonance imaging immediately after craniotomy for detection of metastatic disease. (Kaufman BA, Moran CJ, Park TS) Pediatr Neurosurg 1995;23(4):171-81       5 Citations
1Glossopharyngeal neuralgia associated with vascular compression and choroid plexus papilloma. (Greene KA, Karahalios DG, Spetzler RF) Br J Neurosurg 1995;9(6):809-14       12 Citations
1MR angiography in pediatric neurological disorders. (Lee BC, Park TS, Kaufman BA) Pediatr Radiol 1995;25(6):409-19       28 Citations
1Pancreatitis associated with brain tumor therapy. (Margolis DA, Werlin SL, Murray KJ, Strother DR) Am J Pediatr Hematol Oncol 1994 Nov;16(4):301-4       2 Citations
2Functional magnetic resonance imaging of somatosensory stimulation. (Hammeke TA, Yetkin FZ, Mueller WM, Morris GL, Haughton VM, Rao SM, Binder JR) Neurosurgery 1994 Oct;35(4):677-81       123 Citations
1Immunobiology of malignant astrocytomas. (Kurpad SN, Wikstrand CJ, Bigner DD) Semin Oncol 1994 Apr;21(2):149-61       21 Citations
1Selective incorporation of 111In-labeled PHOTOFRIN by glioma tissue in vivo. (Whelan HT, Kras LH, Ozker K, Bajic D, Schmidt MH, Liu Y, Trembath LA, Uzum F, Meyer GA, Segura AD) J Neurooncol 1994;22(1):7-13       21 Citations
3The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. (Whelan HT, Schmidt MH, Segura AD, McAuliffe TL, Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer GA) J Neurosurg 1993 Oct;79(4):562-8       51 Citations
1Multicystic metastatic carcinoid to brain: case report. (Greene KA, Anson JA, Martinez JA, Spetzler RF, Johnson PC) J Neurooncol 1993 Jul;17(1):15-20       10 Citations
1Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation. (Lundberg JH, Weissman DE, Beatty PA, Ash RC) J Neurooncol 1992 Jun;13(2):151-5       21 Citations
3Interactions of merocyanine 540 with human brain tumor cells. (Whelan HT, Traul DL, Przybylski C, Segura A, Thomas J, Meyer G, Sieber F) Pediatr Neurol 1992;8(2):117-20       6 Citations
1Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. (Weissman DE, Janjan NA, Erickson B, Wilson FJ, Greenberg M, Ritch PS, Anderson T, Hansen RM, Chitambar CR, Lawton CA) J Neurooncol 1991 Dec;11(3):235-9       42 Citations
1Surgical resection of intrinsic brain stem lesions: an overview. (Heffez DS, Zinreich SJ, Long DM) Neurosurgery 1990 Nov;27(5):789-97; discussion 797-8       65 Citations
1Neuroimaging of disseminated germ cell neoplasms. (Mathews VP, Broome DR, Smith RR, Bognanno JR, Einhorn LH, Edwards MK) AJR Am J Roentgenol 1990 Jun;154(6):1299-304       5 Citations
2Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children. (Tang TT, Segura AD, Oechler HW, Harb JM, Adair SE, Gregg DC, Camitta BM, Franciosi RA) Cancer 1990 Apr 01;65(7):1626-34       140 Citations
1Neuroimaging of disseminated germ cell neoplasms. (Mathews VP, Broome DR, Smith RR, Bognanno JR, Einhorn LH, Edwards MK) AJNR Am J Neuroradiol 1990;11(2):319-24       5 Citations
1Correlation of computed tomography and postmortem findings of a diffuse astrocytoma: a case report. (Carter DJ, Wiedmeyer DA, Antuono PG, Ho KC) Comput Med Imaging Graph 1989;13(6):491-4       12 Citations
1Clinical toxicity of interferons in cancer patients: a review. (Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU) J Clin Oncol 1986 Feb;4(2):234-43       598 Citations
1Cervicomedullary junction tumor diagnosed by nuclear magnetic resonance scanning: case report. (Kaufman BA, Kaufman B, Rekate HL) Neurosurgery 1984 Dec;15(6):878-80       7 Citations
1Superficial temporal-middle cerebral artery anastomosis associated with glioblastoma multiforme. (Cusick JF, Komacki S, Choi H) J Neurosurg 1977 Mar;46(3):381-4    
1Association of ossified subdural hematomas and a meningioma. Case report. (Cusick JF, Bailey OT) J Neurosurg 1972 Dec;37(6):731-4       23 Citations